A clinical study of fluconazole for the treatment of deep mycoses
- 31 August 1989
- journal article
- clinical trial
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (4) , 239-247
- https://doi.org/10.1016/0732-8893(89)90143-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitisAntimicrobial Agents and Chemotherapy, 1988
- Fluconazole Penetration into Cerebrospinal Fluid: Implications for Treating Fungal Infections of the Central Nervous SystemThe Journal of Infectious Diseases, 1988
- Selective inhibitory action of fluconazole, an antifungal agent of triazole-derivative, on sterol 14-C demethylation of Candida albicans cells.Japanese Journal of Medical Mycology, 1986
- Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in miceAntimicrobial Agents and Chemotherapy, 1985
- Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humansAntimicrobial Agents and Chemotherapy, 1985
- Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytesAntimicrobial Agents and Chemotherapy, 1985
- Endobronchial Miconazole for Pulmonary AspergillomaAnnals of Internal Medicine, 1983
- FlucytosineAnnals of Internal Medicine, 1977
- Amphotericin B ToxicityAnnals of Internal Medicine, 1969
- Treatment of Pulmonary Aspergilloma With Amphotericin BArchives of internal medicine (1960), 1965